Affordable Access

Publisher Website

Understanding subtype-selective allosteric modulation of GABAA receptors

BMC Pharmacology and Toxicology
Springer (Biomed Central Ltd.)
Publication Date
DOI: 10.1186/2050-6511-13-s1-a26
  • Meeting Abstract
  • Biology


Understanding subtype-selective allosteric modulation of GABAA receptors MEETING ABSTRACT Open Access Understanding subtype-selective allosteric modulation of GABAA receptors Roshan Puthenkalam, Zdravko Varagić, Pantea Mirheydari, Werner Sieghart, Margot Ernst* From 18th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint meeting with the Croatian, Serbian and Slovenian Pharmacological Societies. Graz, Austria. 20-21 September 2012 Background The g-aminobutyric acid type A (GABAA) receptors are the major inhibitory neurotransmitter receptors of the central nervous system. Benzodiazepine (Bz)-site ligands bind at the a/g interface and can enhance GABA-induced Cl− cur- rents. The efficacy of certain benzodiazepines strongly depends on the type of a(1,2,3,5) subunits in the receptors. Functionally selective compounds for a2/3 can be anxioly- tic without having the side effect of sedation. The molecular basis for functional selectivity is investigated in this work. Methods Two-electrode voltage-clamp electrophysiology recordings were performed in wild-type and mutated receptors expressed in Xenopus laevis oocytes. Modelling, docking and molecular dynamics simulation studies of a1g2 and a3g2-containing receptors were performed to understand Bz-ligand interaction with the different a subunits. Results Electrophysiology recordings identified flumazenil as a null modulator in a1 and a weak plus modulator in a3- containing receptors. A sequence comparison between the a1 and a3 subunit revealed the residue R228 as unique for the a3 subunit among all a subunits. a3R228A- mutated receptors completely lost their ability to respond to flumazenil. This amino acid is part of the so-called loop C, a several-residues-spanning segment that forms part of the ligand-binding site with a highly variable sequence. The functionally a3-selective ligand flumazenil was docked into the a/g interface. The flumazenil-bound state in the a1 subtype has already been studied previously

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Selective modulation of GABAA receptors by aluminu...

on Journal of Neurophysiology August 1998

The Di Mascio Lecture. The allosteric modulation o...

on Neuropsychopharmacology June 1991

Allosteric modulation of [3H]EBOB binding to GABAA...

on Neurochemistry International December 2006

Allosteric modulation of GABAA receptors via multi...

on Advances in pharmacology (San... 2015
More articles like this..